Equiniti

Endava Announces Second Quarter Fiscal Year 2024 Results

Retrieved on: 
Thursday, February 29, 2024

Endava plc (NYSE: DAVA) ("Endava" or the "Company"), a leading technology services company combining world-class engineering, industry expertise and a people-centric mindset, today announced results for the three months ended December 31, 2023, the second quarter of its 2024 fiscal year ("Q2 FY2024").

Key Points: 
  • Endava plc (NYSE: DAVA) ("Endava" or the "Company"), a leading technology services company combining world-class engineering, industry expertise and a people-centric mindset, today announced results for the three months ended December 31, 2023, the second quarter of its 2024 fiscal year ("Q2 FY2024").
  • SECOND QUARTER FISCAL YEAR 2024 FINANCIAL HIGHLIGHTS:
    Revenue for Q2 FY2024 was £183.6 million, a decrease of 10.6% compared to £205.2 million in the same period in the prior year.
  • This above guidance for the third quarter and full fiscal year 2024 assumes the exchange rates on January 31, 2024 (when the exchange rate was 1 British Pound to 1.27 US Dollar and 1.17 Euro).
  • The Company will host a conference call at 8:00 am ET today, February 29, 2024, to review its Q2 FY2024 results.

QIAGEN announces details for completion of synthetic share repurchase of up to approximately $300 million

Retrieved on: 
Thursday, January 18, 2024

Venlo, the Netherlands, Jan. 18, 2024 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced details for completion of the synthetic share repurchase plan to return up to approximately $300 million that combines a direct capital repayment to QIAGEN shareholders with a reverse stock split.

Key Points: 
  • Venlo, the Netherlands, Jan. 18, 2024 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced details for completion of the synthetic share repurchase plan to return up to approximately $300 million that combines a direct capital repayment to QIAGEN shareholders with a reverse stock split.
  • The terms of the synthetic share repurchase are as follows:
    Every 25 issued QIAGEN shares will be consolidated into 24.25 QIAGEN shares, leading to a reduction of approximately 6.9 million shares from the level of 230.8 million shares at the end of 2023.
  • Following the implementation of the consolidation, QIAGEN will repay capital to shareholders of record in the amount of $1.28 per pre-split share.
  • (As the par-value of QIAGEN shares is denominated in euros, the amount of the capital decrease and repayment in the respective notarial deeds will also be denominated in euros.

Avalo Therapeutics Announces 1-for-240 Reverse Stock Split

Retrieved on: 
Wednesday, December 27, 2023

The reverse stock split will affect all stockholders uniformly and will not alter any stockholder’s percentage ownership interest in the Company, except to the extent that the reverse stock split results in any of the Company’s stockholders owning a fractional share as described below.

Key Points: 
  • The reverse stock split will affect all stockholders uniformly and will not alter any stockholder’s percentage ownership interest in the Company, except to the extent that the reverse stock split results in any of the Company’s stockholders owning a fractional share as described below.
  • The reverse stock split will reduce the number of shares of common stock issued and outstanding from approximately 192,386,419 to approximately 801,611.
  • As of the effective date of the reverse stock split, the number of shares of common stock available for issuance under the Company’s equity incentive plans and issuable upon the exercise of stock options and warrants outstanding immediately prior to the reverse stock split will be proportionately affected by the reverse stock split.
  • Equiniti, LLC (“EQ”) is acting as the exchange agent for the reverse stock split and will provide instructions to stockholders of record regarding the reverse stock split.

American Battery Materials Issues Clarification on Status of Reverse Stock Split

Retrieved on: 
Wednesday, November 15, 2023

As announced yesterday by FINRA on its Daily List, FINRA completed its review and the reverse stock split was to become effective on the OTC Marketplace at 8:00 AM Eastern time on November 15, 2023.

Key Points: 
  • As announced yesterday by FINRA on its Daily List, FINRA completed its review and the reverse stock split was to become effective on the OTC Marketplace at 8:00 AM Eastern time on November 15, 2023.
  • As such, the reverse stock split has been rescinded pending resolution of the engagement of Equiniti.
  • The Company expects to have the reverse stock split go forward as soon as possible.
  • The combined company is expected to be renamed “American Battery Materials Holdings”, and its common stock and warrants are expected to be listed on the Nasdaq Global Market (“Nasdaq”).

Gouverneur Bancorp, Inc. Announces Closing of Second-Step Conversion and Offering

Retrieved on: 
Tuesday, October 31, 2023

As part of the conversion transaction, each outstanding share of Gouverneur Bancorp common stock owned by the public stockholders of Gouverneur Bancorp (stockholders other than Cambray Mutual Holding Company) as of the closing date was converted into shares of Gouverneur Bancorp, Inc. common stock based on an exchange ratio of 0.5334 shares of Gouverneur Bancorp, Inc. common stock for each share of Gouverneur Bancorp common stock.

Key Points: 
  • As part of the conversion transaction, each outstanding share of Gouverneur Bancorp common stock owned by the public stockholders of Gouverneur Bancorp (stockholders other than Cambray Mutual Holding Company) as of the closing date was converted into shares of Gouverneur Bancorp, Inc. common stock based on an exchange ratio of 0.5334 shares of Gouverneur Bancorp, Inc. common stock for each share of Gouverneur Bancorp common stock.
  • Upon the completion of the conversion and stock offering, Gouverneur Bancorp, Inc. has approximately 1,107,178 shares of common stock outstanding before adjustment for fractional shares.
  • Kilpatrick Townsend & Stockton LLP has acted as legal counsel to Gouverneur Bancorp, Inc. and Gouverneur Bancorp.
  • Keefe, Bruyette & Woods, Inc., a Stifel Company, acted as marketing agent for Gouverneur Bancorp, Inc. in the subscription offering and the community offering and as sole manager in the syndicated community offering.

Gouverneur Bancorp, Inc. Announces Expected Closing Date of Second-Step Conversion

Retrieved on: 
Friday, October 27, 2023

Gouverneur Bancorp, Inc.’s common stock is expected to begin trading on the OTCQB Marketplace under the trading symbol “GOVB” on November 1, 2023.

Key Points: 
  • Gouverneur Bancorp, Inc.’s common stock is expected to begin trading on the OTCQB Marketplace under the trading symbol “GOVB” on November 1, 2023.
  • As part of the conversion transaction, each outstanding share of Gouverneur Bancorp common stock owned by the public stockholders of Gouverneur Bancorp (stockholders other than Cambray Mutual Holding Company) as of the closing date will be converted into shares of Gouverneur Bancorp, Inc. common stock so that Gouverneur Bancorp’s existing public stockholders will own approximately the same percentage of Gouverneur Bancorp, Inc.’s common stock as they owned of Gouverneur Bancorp’s common stock immediately prior to the conversion, subject to adjustment as disclosed in the prospectus.
  • As a result, public stockholders of Gouverneur Bancorp will receive 0.5334 shares of Gouverneur Bancorp, Inc. common stock for each share of Gouverneur Bancorp common stock they own immediately prior to the completion of the transaction.
  • Upon the completion of the conversion and stock offering, approximately 1,107,178 shares of Gouverneur Bancorp, Inc. common stock are expected to be outstanding before adjustment for fractional shares.

Kinetik Announces Third Quarter Dividend and Financial Results Timing

Retrieved on: 
Wednesday, November 1, 2023

Kinetik Holdings Inc. (NYSE: KNTK) (“Kinetik” or the “Company”) has declared a cash dividend of $0.75 per share ($3.00 on an annualized basis) for the third quarter ended September 30, 2023.

Key Points: 
  • Kinetik Holdings Inc. (NYSE: KNTK) (“Kinetik” or the “Company”) has declared a cash dividend of $0.75 per share ($3.00 on an annualized basis) for the third quarter ended September 30, 2023.
  • Kinetik will host its third quarter 2023 results conference call on Thursday, November 9, 2023 at 8:00 am Central Standard Time (9:00 am Eastern Standard Time) to discuss third quarter results.
  • Kinetik previously implemented a Dividend Reinvestment Plan (the “DRIP” or the “Plan”) open to all shareholders.
  • Shareholders who own common stock through a broker should consult their broker regarding participation in the Plan.

Leading Independent Proxy Advisor Glass Lewis Joins ISS in Recommending Shareholders Vote “FOR” Danaher Corporation’s Proposed Acquisition of Abcam

Retrieved on: 
Monday, October 23, 2023

Abcam plc (Nasdaq: ABCM) (‘Abcam,’ the ‘Group’ or the ‘Company’), a global leader in the supply of life science research tools, announced that leading independent proxy advisor, Glass Lewis, recommended that Abcam shareholders vote “FOR” Danaher Corporation’s (“Danaher” or “DHR”) proposed acquisition of Abcam (the “Transaction”) ahead of its shareholder meetings on November 6, 2023.

Key Points: 
  • Abcam plc (Nasdaq: ABCM) (‘Abcam,’ the ‘Group’ or the ‘Company’), a global leader in the supply of life science research tools, announced that leading independent proxy advisor, Glass Lewis, recommended that Abcam shareholders vote “FOR” Danaher Corporation’s (“Danaher” or “DHR”) proposed acquisition of Abcam (the “Transaction”) ahead of its shareholder meetings on November 6, 2023.
  • Alan Hirzel, Chief Executive Officer of Abcam, said: “Following the publication of Glass Lewis’s recommendation on October 21, we’re pleased that both of the world’s leading proxy advisors support our board’s unanimous recommendation that shareholders vote ‘FOR’ the proposed sale to Danaher.
  • Based on these factors, and absent a superior competing offer, we believe the Scheme warrants shareholder support at this time.
  • As such, support for the proposed transaction is warranted.”
    The Board of Directors and management of Abcam recommend shareholders vote “FOR” Danaher’s proposed acquisition of Abcam.

Leading Proxy Advisor, ISS, Recommends Shareholders Vote “FOR” Danaher Corporation’s Proposed Acquisition of Abcam

Retrieved on: 
Tuesday, October 17, 2023

Abcam plc (Nasdaq: ABCM) (‘Abcam,’ the ‘Group’ or the ‘Company’), a global leader in the supply of life science research tools, today announced that leading independent proxy advisor Institutional Shareholder Services (‘ISS’), recommended that Abcam shareholders vote “FOR” Danaher Corporation’s (‘Danaher’ or ‘DHR’) proposed acquisition of Abcam (the ‘Transaction’) ahead of its shareholder meetings on November 6, 2023.

Key Points: 
  • Abcam plc (Nasdaq: ABCM) (‘Abcam,’ the ‘Group’ or the ‘Company’), a global leader in the supply of life science research tools, today announced that leading independent proxy advisor Institutional Shareholder Services (‘ISS’), recommended that Abcam shareholders vote “FOR” Danaher Corporation’s (‘Danaher’ or ‘DHR’) proposed acquisition of Abcam (the ‘Transaction’) ahead of its shareholder meetings on November 6, 2023.
  • Alan Hirzel, Chief Executive Officer of Abcam, said: “We are pleased that ISS supports our board’s unanimous recommendation that shareholders vote “FOR” the proposed sale to Danaher.
  • We are confident this transaction is in the best interests of Abcam and its shareholders, and will deliver an excellent outcome for Abcam’s employees and customers.
  • Other materials related to the upcoming Abcam shareholder vote, including Abcam’s investor presentation are available at https://corporate.abcam.com/investors/danaher-abcam/ .

Abcam Files and Mails Scheme Circular Seeking Approval of Acquisition of Abcam by Danaher for $24.00 per Share

Retrieved on: 
Thursday, October 5, 2023

Under the terms of the Transaction Agreement, Danaher will acquire all of the outstanding shares of Abcam for $24.00 per share in cash.

Key Points: 
  • Under the terms of the Transaction Agreement, Danaher will acquire all of the outstanding shares of Abcam for $24.00 per share in cash.
  • Highlights from the Scheme Circular include:
    The Transaction delivers significant, certain, and immediate value to shareholders.
  • Abcam received multiple bids to acquire the Company, rejected bids it deemed inadequate, and structured a process that induced bidders to increase offers.
  • Danaher’s $24.00 per share in cash offer was the highest and best price received at any point in the process.